quinacrine has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banitt, PF; Guerra, R; Harrison, DG; Myers, PR | 1 |
| Bascands, JL; Bompart, G; Girolami, JP; Pecher, C; Rakotoarivony, J; Tack, JL | 1 |
| Bauersachs, J; Busse, R; Hecker, M | 1 |
| Hisayama, T; Kurata, R; Takayanagi, I | 1 |
4 other study(ies) available for quinacrine and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
| Article | Year |
|---|---|
Characteristics of canine coronary resistance arteries: importance of endothelium.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Atropine; Biological Factors; Blood Pressure; Coronary Vessels; Dogs; Endothelium, Vascular; Female; In Vitro Techniques; Indomethacin; Male; Microscopy, Electron; Muscle, Smooth, Vascular; Nitric Oxide; Potassium; Prostaglandin Endoperoxides, Synthetic; Quinacrine; Thrombin; Vascular Resistance; Vasoconstriction; Vasodilation; Vasopressins | 1989 |
Bradykinin-induced in vitro contraction of rat mesangial cells via a B2 receptor type.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic beta-2 Receptor Antagonists; Angiotensin II; Animals; Arginine Vasopressin; Bombesin; Bradykinin; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cell Membrane; Cells, Cultured; Dinoprost; Dinoprostone; Dose-Response Relationship, Drug; Endothelins; Fatty Acids, Unsaturated; Glomerular Mesangium; Indomethacin; Kinetics; Naphthalenes; Neomycin; Polycyclic Compounds; Prostaglandin Endoperoxides, Synthetic; Protein Kinase C; Quinacrine; Rats; Receptors, Adrenergic, beta-2; Surface Properties; Tetradecanoylphorbol Acetate; Thromboxane A2; Vasoconstrictor Agents | 1994 |
Display of the characteristics of endothelium-derived hyperpolarizing factor by a cytochrome P450-derived arachidonic acid metabolite in the coronary microcirculation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Arachidonic Acid; Arginine; Biological Factors; Bradykinin; Calcium Channel Blockers; Capillaries; Coronary Vessels; Cytochrome P-450 Enzyme System; Diclofenac; Epoprostenol; Female; In Vitro Techniques; Male; Nitric Oxide; Nitroarginine; Nitroprusside; Prostaglandin Endoperoxides, Synthetic; Quinacrine; Rats; Rats, Wistar; Thromboxane A2; Vasoconstrictor Agents; Vasodilation | 1994 |
Eicosanoid-induced Ca2+ release and sustained contraction in Ca(2+)-free media are mediated by different signal transduction pathways in rat aorta.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aorta, Thoracic; Calcium; Culture Media; Dinoprost; Eicosanoids; Flurbiprofen; Fura-2; In Vitro Techniques; Inositol 1,4,5-Trisphosphate; Male; Muscle Contraction; Muscle, Smooth, Vascular; Prostaglandin Endoperoxides, Synthetic; Protein Kinase C; Quinacrine; Rats; Rats, Wistar; Signal Transduction; Tetradecanoylphorbol Acetate; Vasoconstrictor Agents | 1993 |